Companies & Industry >> Quarterly P & L

BSE 23 May 13 | 12:00 AM

215.05		-0.95 (-0.44%)
Mkt Price (Rs)		Chg Rs (Chg %)

Code: 533047

Face Value: 10

218.70		2.75 (1.27%)
Mkt Price (Rs)		Chg Rs (Chg %)

Code: IMFA

Note: 1 crore = 10 million

Rs cr

No Consolidated Avaliable

	Mar 2013	Mar 2012	YOY	Dec 2012	QOQ
Operating Income	379.04	318.49	19.01	311.50	21.68
Material Consumed	183.64	164.79	11.44	171.99	6.77
Manufacturing Expenses	32.61	4.20	676.43	3.24	906.48
Personnel Expenses	31.79	23.47	35.45	24.65	28.97
Cost Of Sales	248.04	192.46	28.88	199.88	24.09
Selling & Adminstrative Expenses	0.00	0.00	N.A.	0.00	N.A.
Other Expenses	79.37	61.74	28.56	53.34	48.80
Expenses	327.41	254.20	28.80	253.22	29.30
Operating Profit	51.63	64.29	-19.69	58.28	-11.41
Other Income	5.62	1.36	313.24	2.14	162.62
PBDIT	57.25	65.65	-12.80	60.42	-5.25
Financial Expenses	21.30	18.30	16.39	18.72	13.78
Depreciation	35.27	17.04	106.98	17.92	96.82
Provisions & Write offs	0.00	0.00	N.A.	0.00	N.A.
PBT	0.68	30.31	-97.76	23.78	-97.14
Tax Charges	12.07	8.27	45.95	8.72	38.42
Reported Net Profit	-11.39	22.04	-151.68	15.06	-175.63
Total Non Recurring Items	0.00	0.00	N.A.	0.00	N.A.
Adjusted Net Profit	-11.39	22.04	-151.68	15.06	-175.63
Equity Dividend (%)	0.00	0.00	N.A.	0.00	N.A.
Reserves and Surplus	0.00	0.00	N.A.	0.00	N.A.

Company	Price	Gain (%)
H D F C	902.95	0.53
Sun Pharma.Inds.	1,006.55	0.46